We have located links that may give you full text access.
Cardiac Manifestation Among Children with Hemolytic Uremic Syndrome.
Journal of Pediatrics 2021 April 3
OBJECTIVE: The primary objectives of the study were to describe the association between cardiac manifestations and in-hospital mortality among children with Hemolytic Uremic Syndrome (HUS).
STUDY DESIGN: Using the Pediatric Health Information System database, this retrospective, multi-center, cohort study identified the first HUS-related inpatient visit among children <=18 years (years 2004 to 2018). Frequency of selected cardiac manifestations and mortality rates were calculated. Multivariate analysis identified the association of specific cardiac manifestations and the risk of in-hospital mortality.
RESULTS: Among 3,915 patients in the analysis, 238 (6.1%) had cardiac manifestations. A majority of patients (82.8%; n=197) had 1 cardiac condition, 17.2% (n=41) had 2, or or more cardiac conditions. The most common cardiac conditions was pericardial disease (n=102), followed by congestive heart failure (n=46), and cardiomyopathy/ myocarditis (n=34). The percent mortality for patients with 0, 1, 2 or more cardiac conditions was 2.1%, 17.3%, and 19.5%, respectively. Patients with any cardiac condition had an increased odds of mortality (OR 9.74; P = .0001). In additional models, the presence of 2 or more cardiac conditions (OR-9.90; p<0.001), cardiac arrest (OR- 38.25; p<0.001), or ECMO deployment (OR- 11.61; p<0.001) were associated with increased risk of in-hospital mortality.
CONCLUSION(S): This study identified differences in in-hospital mortality based on the type of cardiac manifestations, with increased risk observed for patients with multiple cardiac involvement, cardiac arrest, and ECMO deployment.
STUDY DESIGN: Using the Pediatric Health Information System database, this retrospective, multi-center, cohort study identified the first HUS-related inpatient visit among children <=18 years (years 2004 to 2018). Frequency of selected cardiac manifestations and mortality rates were calculated. Multivariate analysis identified the association of specific cardiac manifestations and the risk of in-hospital mortality.
RESULTS: Among 3,915 patients in the analysis, 238 (6.1%) had cardiac manifestations. A majority of patients (82.8%; n=197) had 1 cardiac condition, 17.2% (n=41) had 2, or or more cardiac conditions. The most common cardiac conditions was pericardial disease (n=102), followed by congestive heart failure (n=46), and cardiomyopathy/ myocarditis (n=34). The percent mortality for patients with 0, 1, 2 or more cardiac conditions was 2.1%, 17.3%, and 19.5%, respectively. Patients with any cardiac condition had an increased odds of mortality (OR 9.74; P = .0001). In additional models, the presence of 2 or more cardiac conditions (OR-9.90; p<0.001), cardiac arrest (OR- 38.25; p<0.001), or ECMO deployment (OR- 11.61; p<0.001) were associated with increased risk of in-hospital mortality.
CONCLUSION(S): This study identified differences in in-hospital mortality based on the type of cardiac manifestations, with increased risk observed for patients with multiple cardiac involvement, cardiac arrest, and ECMO deployment.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app